Kalii Citratis Fono Viii. Naturland

Potassium citrate, the active ingredient in Kalii Citratis Fono Viii. Naturland, is a potassium salt presented as an oral electrolyte supplement for oral use. It helps correct low blood potassium levels and alkalinizes urine, which is useful in conditions such as hypokalemia, renal tubular acidosis and kidney stone prevention.

GNH USA supplies Kalii Citratis Fono Viii. Naturland as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Potassium citrate is used to manage electrolyte balance and urinary chemistry in several clinical conditions.

- Hypokalemia: restores potassium levels to prevent cardiac and muscular complications. - Renal tubular acidosis: provides alkali to correct systemic acidosis and improve renal function. - Prevention of kidney stones: increases urinary citrate, which binds calcium and reduces stone formation.

Potassium citrate may cause adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset after ingestion. - Abdominal discomfort: cramping or pain in the upper abdomen. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools occurring shortly after dosing. - Taste alteration: metallic or salty taste in the mouth. - Flatulence: increased gas production.

Serious or Rare Side Effects: - Hyperkalemia: dangerously high potassium levels that can affect heart rhythm. - Metabolic alkalosis: excessive alkalinity of the blood. - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Cardiac arrhythmia: irregular heartbeats due to electrolyte imbalance. - Paradoxical kidney stone formation: rare cases where stone risk increases.

Before initiating therapy with potassium citrate, several safety considerations should be observed.

- Serum potassium assessment: verify baseline potassium levels to avoid hyperkalemia. - Renal function monitoring: adjust dosage in patients with impaired kidney function. - Concomitant medication review: be cautious with drugs that raise potassium, such as ACE inhibitors. - Avoid in existing hyperkalemia: do not use if serum potassium is already elevated. - Pregnancy and lactation: use only if the potential benefit outweighs risk, after medical evaluation. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Potassium citrate can interact with several medicines, affecting potassium balance or renal excretion.

Major Interactions (Avoid): - ACE inhibitors/ARBs: may cause additive hyperkalemia. - Potassium‑sparing diuretics (e.g., spironolactone): increase risk of dangerous potassium elevation. - NSAIDs: can reduce renal potassium excretion, raising serum levels. - Trimethoprim: may impair potassium clearance, leading to hyperkalemia.

Moderate Interactions (Monitor Closely): - Digoxin: serum potassium changes can alter digoxin toxicity risk. - Lithium: altered renal handling may affect lithium levels. - Certain antibiotics (e.g., penicillins): may affect renal function, requiring potassium monitoring.